Agalsidase-β should be proposed as first line therapy in classic male Fabry patients with undetectable α-galactosidase A activity

Nowak, AlbinaAlbinaNowakDormond, OlivierOlivierDormondMonzambani, VéroniqueVéroniqueMonzambaniHuynh-Do, UyenUyenHuynh-Do0000-0002-7276-032XBarbey, FrédéricFrédéricBarbey2024-10-252024-10-252022https://boris-portal.unibe.ch/handle/20.500.12422/165597en600 - Technology::610 - Medicine & health500 - Science::570 - Life sciences; biologyAgalsidase-β should be proposed as first line therapy in classic male Fabry patients with undetectable α-galactosidase A activityarticle10.48350/1806603608750510.1016/j.ymgme.2022.08.003